All Stories

  1. Enteroaggregative Escherichia clade I from Nigeria
  2. Refining the Serine Protease Autotransporters of Enterobacteriaceae (SPATE) gene detection in Enteroaggregative Escherichia coli genomes uncovers differential SPATE distribution by phylogeny
  3. Identification of Antibiofilm Agents against Salmonella enterica from the Pathogen Box Compound Library
  4. Genomic characterization of resistant Escherichia coli isolated from household water in municipal Ibadan, Nigeria
  5. Knowledge, Attitudes, and Perceptions Surrounding Antibiotic Use: Exploring Social Determinants of Antibiotic Misuse in Peri-Urban Nigeria
  6. Community-led Strategies for Ameliorating Antimicrobial Resistance in Nigeria:  Research Protocol for a Participatory Action Research Project
  7. Stakeholder Views on Lessons Learned for the Antimicrobial Resistance Panel from Previous International Science Panels
  8. Genomic epidemiology of enteropathogenic Escherichia coli in southwestern Nigeria
  9. Barriers and facilitators to digital technology application for antimicrobial resistance surveillance: A co-produced qualitative synthesis
  10. Slow-growing Salmonella enterica serovariety Typhi mis-identified as serovariety Gallinarum in Ibadan, Nigeria
  11. Transmissible antimicrobial resistance in Escherichia coli isolated from household drinking water in Ibadan, Nigeria
  12. Case Report: Detection of invasive mcr-10 harbouring Klebsiella quasipneumoniae subsp. similipneumoniae in a patient with chronic myeloid leukaemia.
  13. Beyond high cost: Pharmaceutic low-resource setting barriers to antibacterial access
  14. Decentralising Bioinformatics Capacity: Lessons from Training Hospital Staff and Field Epidemiologists in Nigeria
  15. Genomic epidemiology of enteropathogenic Escherichia coli(EPEC) in southwestern Nigeria
  16. Genomic characterization of foodborne Salmonella enterica and Escherichia coli isolates from Saboba district and Bolgatanga Municipality Ghana
  17. Transmissible antimicrobial resistance in Escherichia coli isolated from household drinking water in Ibadan, Nigeria
  18. Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium
  19. Slow-growingSalmonella entericaTyphi mis-identified asSalmonellaGallinarum in Ibadan, Nigeria
  20. Genetic basis for antimicrobial resistance inEscherichia coliisolated from household water in municipal Ibadan, Nigeria
  21. Whole Genome Sequencing RevealsEnterobacter hormaecheias a Key Bloodstream Pathogen in Six Tertiary Care Hospitals in Southwestern Nigeria
  22. Occurrence of Salmonella enterica in faecal sludge from Nigeria and genetic relatedness with strains associated with human infections in Africa
  23. A Systematic Review of Antibiotic Use in Humans in Nigeria and its Potential Contribution to Rising Antimicrobial Resistance
  24. A Systematic Review of Antibiotic Use in Humans in Nigeria and its Potential Contribution to Rising Antimicrobial Resistance
  25. NDM-1- and OXA-23-producing Acinetobacter baumannii in wastewater of a Nigerian hospital
  26. PCR diagnostics are insufficient for the detection of Diarrhoeagenic Escherichia coli in Ibadan, Nigeria
  27. Evaluation of fecal occult blood testing for rapid diagnosis of invasive diarrhea in young children
  28. Prevalence and whole genome phylogenetic analysis reveal genetic relatedness between antibiotic resistance Salmonella in hatchlings and older chickens from farms in Nigeria
  29. Evaluation of Fecal Occult Blood Testing Kits for Rapid Point-of-Care Diagnosis of Invasive Diarrhea in Young Children
  30. Insufficiency of PCR diagnostics for Detection of DiarrhoeagenicEscherichia coliin Ibadan, Nigeria
  31. Antibiofilm agents with therapeutic potential against enteroaggregative Escherichia coli
  32. Epidemiology and risk factors for diarrhoeagenic Escherichia coli carriage among children in northern Ibadan, Nigeria
  33. Establishing a national reference laboratory for antimicrobial resistance using a whole-genome sequencing framework: Nigeria’s experience
  34. Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria
  35. A bottom-up view of antimicrobial resistance transmission in developing countries
  36. Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria
  37. Towards a fiercely urgent expansion of laboratory medicine in Africa
  38. Antibiofilm agents with therapeutic potential against enteroaggregative Escherichia coli
  39. Twenty steps to ingrain power asymmetry in global health biomedical research
  40. The importance of molecular diagnostics for infectious diseases in low-resource settings
  41. Bacteria autoaggregation: how and why bacteria stick together
  42. Genomic Analysis of Antimicrobial Resistance and Resistance Plasmids in Salmonella Serovars from Poultry in Nigeria
  43. African laboratory medicine in the time of COVID-19
  44. A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants
  45. A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants
  46. Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings
  47. A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants
  48. Editorial overview: Paths of least resistance: surveillance, discovery, and innovation to address the other (antimicrobial resistance) pandemic
  49. A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants
  50. The Not so Good, the Bad and the Ugly: Differential Bacterial Adhesion and Invasion Mediated by Salmonella PagN Allelic Variants
  51. Extending the breadth of African laboratory medicine
  52. A large self-transmissible resistance plasmid from Nigeria contains genes that ameliorate a carrying cost
  53. Quality assessment of bacterial identification and antimicrobial susceptibility testing in African national health laboratories, 2011 - 2016
  54. A large self-transmissible plasmid from Nigeria confers resistance to multiple antibacterials without a carrying cost
  55. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis
  56. Antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa: A systematic review
  57. Antimicrobial resistance surveillance in Africa: Successes, gaps and a roadmap for the future
  58. Building resources to meet evolving laboratory medicine challenges in Africa
  59. Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action
  60. Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action
  61. Interplay of surface factors in colonization by a diarrhea pathogen
  62. Enteroaggregative Escherichia coli Have Evolved Independently as Distinct Complexes within the E. coli Population with Varying Ability to Cause Disease
  63. Dissemination of the Transmissible Quinolone-Resistance Gene qnrS1 by IncX Plasmids in Nigeria
  64. Diagnostic schemes for reducing epidemic size of african viral hemorrhagic fever outbreaks
  65. Comparative genomics of 274 Vibrio cholerae genomes reveals mobile functions structuring three niche dimensions
  66. Cholera Outbreaks in Nigeria Are Associated with Multidrug Resistant Atypical El Tor and Non-O1/Non-O139 Vibrio cholerae
  67. Regional Dissemination of a Trimethoprim-Resistance Gene Cassette via a Successful Transposable Element
  68. Vibrio cholerae O1 lineages driving cholera outbreaks during seventh cholera pandemic in Ghana
  69. Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use
  70. Non-prescription antimicrobial use worldwide: a systematic review
  71. The Heat-Resistant Agglutinin Family Includes a Novel Adhesin from Enteroaggregative Escherichia coli Strain 60A
  72. Diagnostics as essential tools for containing antibacterial resistance
  73. Ensuring Global Access to Quality Medicines: Role of the US Pharmacopeia
  74. IS3 profiling identifies the enterohaemorrhagic Escherichia coli O-island 62 in a distinct enteroaggregative E. coli lineage
  75. Quinolone resistance in Escherichia coli from Accra, Ghana
  76. Multi-Locus Sequence Typing of Enteroaggregative Escherichia coli Isolates from Nigerian Children Uncovers Multiple Lineages
  77. Carriage of diarrhoeagenic Escherichia coli by older children and adults in Accra, Ghana
  78. A Pathoadaptive Deletion in an Enteroaggregative Escherichia coli Outbreak Strain Enhances Virulence in a Caenorhabditis elegans Model
  79. African Researchers Underrepresented
  80. Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil
  81. Cholera Vaccine Will Reduce Antibiotic Use
  82. Heat-Resistant Agglutinin 1 Is an Accessory Enteroaggregative Escherichia coli Colonization Factor
  83. The Escherichia coli Common Pilus and the Bundle-Forming Pilus Act in Concert during the Formation of Localized Adherence by Enteropathogenic E. coli
  84. The commonly-used DNA probe for diffusely-adherent Escherichia coli cross-reacts with a subset of enteroaggregative E. coli
  85. The Plasmid-Encoded Regulator Activates Factors Conferring Lysozyme Resistance on Enteropathogenic Escherichia coli Strains
  86. Post-genomic challenges for collaborative research in infectious diseases
  87. Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element
  88. Connecting loose ends: a unique linear plasmid or a new model system?
  89. Growing Problem of Multidrug-Resistant Enteric Pathogens in Africa
  90. A Second Large Plasmid Encodes Conjugative Transfer and Antimicrobial Resistance in O119:H2 and Some Typical O111 Enteropathogenic Escherichia coli Strains
  91. EnteroaggregativeEscherichia coliRelated to Uropathogenic Clonal Group A
  92. Error-Prone DNA Repair System in Enteroaggregative Escherichia coli Identified by Subtractive Hybridization
  93. Diagnostic Insufficiency in Africa
  94. Antimicrobial resistance in developing countries. Part II: strategies for containment
  95. Antimicrobial resistance in developing countries. Part I: recent trends and current status
  96. Stopping the Spread of Drug-Resistant Malaria
  97. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries
  98. Molecular Epidemiology of the Iron Utilization Genes of Enteroaggregative Escherichia coli
  99. Etiology of Acute Diarrhea in Adults in Southwestern Nigeria
  100. Antibiotic-Resistant Cell-Detaching Escherichia coli Strains from Nigerian Children
  101. Enteroaggregative Escherichia coli
  102. Bacteriological quality of skin-moisturizing creams and lotions distributed in a tropical developing country
  103. Comparative Sequence Analysis of the Plasmid-Encoded Regulator of Enteropathogenic Escherichia coliStrains
  104. Microbiological investigation of an outbreak of acute gastroenteritis in Niger State, Nigeria
  105. Dissemination of Antibiotic‐Resistant Bacteria across Geographic Borders
  106. espC Pathogenicity Island of Enteropathogenic Escherichia coli Encodes an Enterotoxin
  107. Antibiotic Resistance in Escherichia coli from Nigerian Students, 1986-1998
  108. Heterogeneous Virulence of EnteroaggregativeEscherichia coliStrains Isolated from Children in Southwest Nigeria
  109. Antimicrobial spectrum ofAlchornea cordifolia leaf extract
  110. Socioeconomic and Behavioral Factors Leading to Acquired Bacterial Resistance to Antibiotics in Developing Countries